HUMA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

HUMAHumacyte, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

HUMAHumacyte, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

HUMAHumacyte, Inc.

0.41▼−7.82%

Mkt cap$122.4MRevenue$406,000Q2 FY26Revenue$2MFY25

AMGNAmgen Inc

479.74▲+0.26%

Regular sessionNov 5 '26

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 5 '26

HUMAHumacyte, Inc.

AMGNAmgen Inc

0.41▼−7.82%

Price

479.74▲+0.26%

$122.4M

Mkt cap

$258.8B

Q2 FY26$406,000

Revenue

$10.4BQ3 FY26

FY25$2M

Revenue

$36.8BFY25

HUMA0.41▼−7.82%vsAMGN479.74▲+0.26%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

HUMA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only HUMA 4

TMOThermo Fisher Scientificsupplier

FMSFresenius Medical Carecustomer

—Confluent Medical Technologiesunlistedsupplier

—SeraCareunlistedsupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

HUMA, solidAMGN, dashed